Yap, Timothy A.
Aerts, Joachim G.
Popat, Sanjay
Fennell, Dean A.
Article History
First Online: 25 July 2017
Competing interests
: T.A.Y. is consultant to AstraZeneca, Roche, Pfizer, Bristol-Myers Squibb (BMS), EMD Serono, Clovis Oncology and Ignyta, Inc., has received research funding from AstraZeneca, Vertex and Clearbridge Biomedics, and has received travel support from AstraZeneca, GlaxoSmithKline, EMD Serono, Merck Sharp and Dohme (MSD) Oncology, Janssen-Cilag, Vertex and BMS. J.G.A. is consultant/speaker for AstraZeneca, Boehringer Ingelheim, Eli Lilly, MSD, BMS, Roche and Amphera, has received travel expenses from Pfizer, Merck, Boehringer Ingelheim, Verastem and Amphera, and has received research funding from Roche. S.P. is consultant to Ariad, AstraZeneca, Boehringer Ingelheim, BMS, Clovis Oncology, MSD, Novartis, Pfizer and Eli Lilly, has received honoraria from Boehringer Ingelheim, Pfizer and Eli Lilly, travel expenses from Boehringer Ingelheim, BMS, MSD and Pfizer, and research funding from Boehringer Ingelheim and Pierre Fabre. D.A.F. is consultant to Aduro, AstraZeneca, Bayer, Boehringer Ingelheim, Clovis, Medimmune, Lab 21, Lilly, Merck, Pierre Fabre, Roche-Genentech, member of speakers bureaux for BMS, Merck and AstraZeneca.